APOE and Parkinson disease: In de novo PD patients aged >65, male, ill-educated (<13 years) and without carrying APOE ε4, we found the predictive effects of CSF NfL baseline concentration and longitudinal rate on cognitive decline appeared to be more remarkable and comprehensive.